The serum separation gel market size has grown strongly in recent years. It will grow from $8.92 billion in 2024 to $9.74 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the surge in the current healthcare expenditure, increased demand for diagnostic testing, growth of the healthcare industry, expansion of research and development activities, and rise in prevalence of chronic diseases.
The serum separation gel market size is expected to see strong growth in the next few years. It will grow to $13.71 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to the increasing incidence of hematologic disorders, emphasis on point-of-care testing, increased number of contract research organizations, expansion in emerging markets, and demand for personalized medicine. Major trends in the forecast period include personalized medicine applications, development of novel gel formulations, increased focus on eco-friendly and sustainable practices, integration with digital health technologies, and growth in research for infectious disease diagnostics.
The serum separation gel market is poised for growth driven by the rising demand for diagnostic testing. Diagnostic testing involves identifying diseases or conditions in individuals by analyzing biological samples like blood or tissue for specific markers or abnormalities. The increasing demand for diagnostic testing stems from its role in detecting diseases early, aiding in effective treatment, and guiding preventive healthcare measures. Serum separation gel plays a crucial role in diagnostic testing by separating serum from blood cells, enabling accurate analysis of biochemical markers and disease detection. For example, data from March 2024 by the House of Commons indicates a 13% increase in diagnostic tests in January 2024 compared to January 2020, underscoring the growth in demand for diagnostic testing and its impact on the serum separation gel market.
Key players in the serum separation gel market are focusing on developing innovative product solutions like serum fast separator tubes to stay competitive. Serum fast separator tubes are designed with specialized gel or clot activator additives that facilitate rapid serum separation following centrifugation. For instance, in May 2023, Greiner Bio-One introduced the VACUETTE CAT Serum Fast Separator tube, which enables complete coagulation of whole blood samples in about 5 minutes, offering a significant time advantage over standard serum tubes. The tube's interior is coated with blood clot activator and thrombin, and it contains a gel barrier between serum and solid components. Thrombin accelerates the clotting process in blood samples, enhancing efficiency in diagnostic testing processes.
The increasing prevalence of chronic diseases is expected to drive the growth of the serum separation gel market. A chronic disease is a long-term condition that typically lasts for more than three months and often requires ongoing medical care or limits daily activities. The rise in chronic diseases can be attributed to factors such as aging populations, unhealthy lifestyles, and medical advancements that enable people with acute conditions to live longer, leading to a higher prevalence of long-term health issues. Serum separation gel is used in blood collection tubes to facilitate the separation of serum, which helps in the accurate diagnosis and monitoring of biomarkers related to chronic diseases. For example, a report published in August 2022 by the American College of Cardiology, a US-based non-profit medical association, projected that from 2025 to 2060, all four major cardiovascular risk factors in the United States would increase. Diabetes is expected to experience the largest rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). Additionally, significant increases in cardiovascular diseases, such as stroke (up 33.8% to 15 million) and heart failure (up 33.4% to 13 million), are expected, along with ischemic heart disease (up 30.7% to 29 million) and heart attacks (up 16.9% to 16 million). As a result, the growing prevalence of chronic diseases is fueling the demand for serum separation gel.
Major companies operating in the serum separation gel market report are Cardinal Health Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Corning Incorporated; Bio-Rad Laboratories Inc.; Qiagen NV; Bio-Techne Corporation; Greiner Bio-One International GmbH; Sarstedt AG & Co. KG; Sekisui Diagnostics LLC; InterVac Technology Corporation; BioVision Inc.; Deltalab S.L.; Narang Medical Limited; Biosigma S.p.A.; BIOSIGMA S.r.l.; Helena Biosciences; FL Medical Srl; Kabe Labortechnik GmbH.
North America was the largest region in the serum separation gel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum separation gel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the serum separation gel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The serum separation gel market consists of sales of silica-based and polymer-based serum separation gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
Serum separation gel is a specialized substance utilized to isolate serum from whole blood samples, streamlining subsequent analysis in clinical and research environments. It is incorporated into blood collection tubes to establish a physical barrier between serum and blood cells, aiding in the separation process during centrifugation.
The primary types of serum separation gel include integrated tubes and standalone gel formulations. Integrated tubes feature blood collection tubes pre-coated or equipped with serum separation gels, simplifying serum isolation during sample collection. These formulations may include powder gel or liquid gel variations and are utilized across various sectors, including hospitals, clinics, pharmaceutical and biotechnology firms, diagnostic laboratories, and blood banks.
The serum separation gel market research report is one of a series of new reports that provides serum separation gel market statistics, including serum separation gel industry global market size, regional shares, competitors with serum separation gel market share, detailed serum separation gel market segments, market trends, and opportunities, and any further data you may need to thrive in the serum separation gel industry. This serum separation gel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Serum Separation Gel Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on serum separation gel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for serum separation gel? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The serum separation gel market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Serum Separation Gel Integrated With Tube; Serum Separation Gel Without Tube2) By Formulation: Powder Gel; Liquid Gel
3) By End User: Hospitals And clinics; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Blood Banks
Subsegments:
1) By Serum Separation Gel Integrated With Tube: Plastic Tubes With Serum Separation Gel; Glass Tubes With Serum Separation Gel2) By Serum Separation Gel Without Tube: Pre-filled Gel Packs; Bulk Serum Separation Gel For Custom Tubes
Key Companies Mentioned: Cardinal Health Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Corning Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Serum Separation Gel market report include:- Cardinal Health Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton Dickinson and Company
- Corning Incorporated
- Bio-Rad Laboratories Inc.
- Qiagen NV
- Bio-Techne Corporation
- Greiner Bio-One International GmbH
- Sarstedt AG & Co. KG
- Sekisui Diagnostics LLC
- InterVac Technology Corporation
- BioVision Inc.
- Deltalab S.L.
- Narang Medical Limited
- Biosigma S.p.A.
- BIOSIGMA S.r.l.
- Helena Biosciences
- FL Medical Srl
- Kabe Labortechnik GmbH
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | March 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 9.74 Billion |
Forecasted Market Value ( USD | $ 13.71 Billion |
Compound Annual Growth Rate | 8.9% |
Regions Covered | Global |
No. of Companies Mentioned | 21 |